CARM
Carisma Therapeutics
CARM
CARM
Delisted
CARM was delisted on the 10th of October, 2025.
33 hedge funds and large institutions have $1.38M invested in Carisma Therapeutics in 2025 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
33
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$182K | |
| 2 | +$7.55K | |
| 3 | +$3.73K | |
| 4 |
Goldman Sachs
New York
|
+$1.12K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$21 |
Top Sellers
| 1 | -$281K | |
| 2 | -$59.1K | |
| 3 | -$11.8K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$4.98K |
| 5 |
BBA
Baader Bank Aktiengesellschaft
Unterschleissheim,
Germany
|
-$4.45K |
